Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe

Ustun, C; Idilman, RAMAZAN; GÜRMAN, GÜNHAN; Ozcan, MUHİT; Akyol, G; Akan, H; Ilhan, O; BEKSAÇ, MERAL; Uysal, A; Konuk, N; Karayalcin, S; Poyraz, A; Van Thiel, D; Koc, H

doi:10.1016/s0168-8278(99)80214-1

Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe

Ustun C., Idilman R., GÜRMAN G., Ozcan M., Akyol G., Akan H., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.31, sa.2, ss.202-209, 1999 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 31 Sayı: 2
Basım Tarihi: 1999
Doi Numarası: 10.1016/s0168-8278(99)80214-1
Dergi Adı: JOURNAL OF HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.202-209
Anahtar Kelimeler: adoptive immunity, hepatitis B virus, immunosuppression, liver, stem cell transplantation, BONE-MARROW TRANSPLANTATION, CHRONIC VIRAL-HEPATITIS, VERSUS-HOST DISEASE, ADOPTIVE TRANSFER, LIVER-DISEASE, SURFACE-ANTIGEN, INFECTION, IMMUNITY, DONORS, RECONSTITUTION
Ankara Üniversitesi Adresli: Evet

Özet

Background/Aims: Hepatitis B virus can cause serious problems in individuals undergoing organ transplantation. The aim of this study was to evaluate the hepatic events among HBs-Ag positive recipients and HBs-Ag negative recipients who received products from hepatitis B virus carriers.